NantCell (formerly known as ImmunityBio) is an immunotherapy company focusing on cell-based treatments against cancer and infectious diseases. It develops combinations of chemo-immune sensitizers, cell therapies, cytokines, vaccines, neoepitopes, and monoclonal antibody immunotherapies.